Bictegravir / Emtricitabine / Tenofovir AF

Also known as Biktarvy (us)

Save $4,055/mo

87× cheaper

BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologicall…

United States

$4,102

per month

India

$47

per month

You save

$4,055

99% cheaper in India

840.8K US scripts/yr$3.4B potential annual savings$3.4B US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

Strength & form

US price$4,099per month

India priceNot availableno India data yet

You save—add India price to compare

Based on 30 EAs per month. US $136.64 per unit — India price not available for this variant.

How many months / courses?

Total over 1 periodIndia price not availableUS total $4,099

The bigger picture

Bictegravir / Emtricitabine / Tenofovir AF is filled about 840.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$3.4B

If sourced from India

$39.5M

Potential annual savings

$3.4B

−99%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.